Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-04-28 4:17 pm Sale | 13G | Provention Bio Inc. PRVB | Sessa Capital (Master) L.P. | 0 0.000% | -18,403,628 (Position Closed) | View |
| 2023-04-05 08:51 am Purchase | 13G | Provention Bio Inc. PRVB | Sessa Capital (Master) L.P. | 18,403,628 17.800% | 337,015 (+1.87%) | View |
| 2023-02-21 4:50 pm Purchase | 13G | Provention Bio Inc. PRVB | ADAGE CAPITAL PARTNERS GP L.L.C. | 5,398,825 6.010% | 2,879,568 (+114.30%) | View |
| 2023-02-14 4:08 pm Sale | 13G | Provention Bio Inc. PRVB | Venrock Healthcare Capital Partners II L.P. | 1,118,653 1.300% | -2,725,143 (-70.90%) | View |
| 2023-02-14 3:00 pm Purchase | 13G | Provention Bio Inc. PRVB | Sessa Capital (Master) L.P. | 18,066,613 19.990% | 2,456,443 (+15.74%) | View |
| 2023-02-09 11:07 am Sale | 13G | Provention Bio Inc. PRVB | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,519,257 2.890% | -2,780,743 (-52.47%) | View |
| 2023-01-31 5:52 pm Purchase | 13G | Provention Bio Inc. PRVB | BlackRock Inc. BLK | 5,579,604 6.400% | 1,095,679 (+24.44%) | View |
| 2022-08-26 4:30 pm Purchase | 13G | Provention Bio Inc. PRVB | ADAGE CAPITAL PARTNERS GP L.L.C. | 5,300,000 6.500% | 5,300,000 (New Position) | View |
| 2022-07-11 5:29 pm Purchase | 13G | Provention Bio Inc. PRVB | Sessa Capital (Master) L.P. | 15,610,170 19.990% | 9,714,645 (+164.78%) | View |
| 2022-02-14 5:29 pm Purchase | 13G | Provention Bio Inc. PRVB | Sessa Capital (Master) L.P. | 5,895,525 9.300% | 5,895,525 (New Position) | View |
| 2022-02-14 5:18 pm Sale | 13G | Provention Bio Inc. PRVB | PERCEPTIVE ADVISORS LLC | 948,481 1.500% | -2,684,542 (-73.89%) | View |
| 2022-02-03 4:29 pm Purchase | 13G | Provention Bio Inc. PRVB | BlackRock Inc. BLK | 4,483,925 7.100% | 558,436 (+14.23%) | View |
| 2021-06-07 4:30 pm Purchase | 13G | Provention Bio Inc. PRVB | Venrock Healthcare Capital Partners II L.P. | 3,843,796 6.100% | 3,843,796 (New Position) | View |
| 2021-04-19 4:30 pm Sale | 13G | Provention Bio Inc. PRVB | PERCEPTIVE ADVISORS LLC | 3,633,023 5.700% | -591,366 (-14.00%) | View |
| 2021-02-16 5:02 pm Purchase | 13G | Provention Bio Inc. PRVB | APPEL PETER A | 2,262,500 4.010% | 312,500 (+16.03%) | View |
| 2021-02-16 3:33 pm Purchase | 13G | Provention Bio Inc. PRVB | PERCEPTIVE ADVISORS LLC | 4,224,389 6.700% | 1,302,815 (+44.59%) | View |
| 2021-02-05 4:31 pm Unchanged | 13G | Provention Bio Inc. PRVB | AMGEN INC AMGN | 2,500,000 4.426% | 0 (Unchanged) | View |
| 2021-02-02 3:13 pm Purchase | 13G | Provention Bio Inc. PRVB | BlackRock Inc. BLK | 3,925,489 6.900% | 3,925,489 (New Position) | View |
| 2020-02-20 4:24 pm Sale | 13G | Provention Bio Inc. PRVB | MACROGENICS INC MGNX | 0 0.000% | -2,432,688 (Position Closed) | View |
| 2020-02-18 3:41 pm Purchase | 13G | Provention Bio Inc. PRVB | PERCEPTIVE ADVISORS LLC | 2,921,574 6.100% | 2,921,574 (New Position) | View |